will tirzepatide go back on the shortage list Mounjaro remain off after FDA review Drugmakers battle pharmacies over compounded
Description
The new rule would expand access to drugs such as Wegovy and Zepbound for an additional 3.4 million Americans who use Medicare and another 4 million people enrolled in Medicaid.
The authorization could ease cost pressures on group benefit plan sponsors covering GLP-1 drugs
Targeted Postbiotics Deliver active compounds that drive real results
2026 guide: recipe, GLP-1 science, and who it helps.
Subscribe & save option
